Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity

Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity

Abstract Background Schistosomiasis is a devastating parasitic disease. The mainstay of schistosomiasis control is by praziquantel treatment. The study aimed to determine benefits of annual chemotherapy of schistosomiasis on development of protective immunity in school children in a selected endemic...

Full description

Bibliographic Details
Main Authors: Tawanda J. Chisango, Bongiwe Ndlovu, Arthur Vengesai, Agness Farai Nhidza, Edson P. Sibanda, Danai Zhou, Francisca Mutapi, Takafira Mduluza
Format: Article
Language:English
Published: BMC 2019-03-01
Series:BMC Infectious Diseases
Subjects:
Praziquantel
Schistosomiasis
MDA
Treatment
Antibodies
Immunity
Online Access:http://link.springer.com/article/10.1186/s12879-019-3811-z

Internet

http://link.springer.com/article/10.1186/s12879-019-3811-z

Similar Items